{"related:o-CHz8dQSiYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1803675","authors":["A Méjean","A Méjean A Ravaud","A Méjean A Ravaud S Thezenas…"],"year":2018,"numCitations":332,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1803675","citationUrl":"http://scholar.google.com/scholar?cites=2759106540828352675&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:o-CHz8dQSiYJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2759106540828352675&hl=en&as_sdt=0,5","publication":"Mass Medical Soc","p":1,"exp":1596898396756},{"title":"Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME …","url":"https://jamanetwork.com/journals/jamaoncology/article-abstract/2718007","authors":["A Bex","A Bex P Mulders","A Bex P Mulders M Jewett","A Bex P Mulders M Jewett J Wagstaff…"],"year":2019,"numCitations":121,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439568/","citationUrl":"http://scholar.google.com/scholar?cites=8989007195462601834&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:aoz6IGtev3wJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8989007195462601834&hl=en&as_sdt=0,5","publication":"jamanetwork.com"},{"title":"Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma …","url":"https://www.sciencedirect.com/science/article/pii/S0302283814004941","authors":["DYC Heng","DYC Heng JC Wells","DYC Heng JC Wells BI Rini","DYC Heng JC Wells BI Rini B Beuselinck","DYC Heng JC Wells BI Rini B Beuselinck JL Lee…"],"year":2014,"numCitations":324,"pdf":"http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.923.7779&rep=rep1&type=pdf","citationUrl":"http://scholar.google.com/scholar?cites=16056062960886333100&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:rL7vujGY0t4J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16056062960886333100&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Cytoreductive nephrectomy—patient selection is key","url":"https://www.nejm.org/doi/full/10.1056/NEJMe1806331","authors":["RJ Motzer","RJ Motzer P Russo"],"year":2018,"numCitations":49,"citationUrl":"http://scholar.google.com/scholar?cites=6960074034349422989&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:jTnRS3Uml2AJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6960074034349422989&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a National Cancer Data …","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5024547/","authors":["N Hanna","N Hanna M Sun","N Hanna M Sun CP Meyer","N Hanna M Sun CP Meyer PL Nguyen…"],"year":2016,"numCitations":143,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5024547/","citationUrl":"http://scholar.google.com/scholar?cites=6370661562938301626&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:uhwsM_AiaVgJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6370661562938301626&hl=en&as_sdt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Systematic review of the role of cytoreductive nephrectomy in the targeted therapy era and beyond: an individualized approach to metastatic renal cell carcinoma","url":"https://www.sciencedirect.com/science/article/pii/S0302283818306663","authors":["B Bhindi","B Bhindi EJ Abel","B Bhindi EJ Abel L Albiges","B Bhindi EJ Abel L Albiges K Bensalah","B Bhindi EJ Abel L Albiges K Bensalah SA Boorjian…"],"year":2019,"numCitations":54,"citationUrl":"http://scholar.google.com/scholar?cites=5080729603362799870&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:_kBAyKdggkYJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5080729603362799870&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1712126","authors":["RJ Motzer","RJ Motzer NM Tannir","RJ Motzer NM Tannir DF McDermott…"],"year":2018,"numCitations":1247,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1712126","citationUrl":"http://scholar.google.com/scholar?cites=13898631485117911629&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:TVKDlrLb4cAJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13898631485117911629&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?","url":"https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.25046","authors":["SH Culp","SH Culp NM Tannir","SH Culp NM Tannir EJ Abel","SH Culp NM Tannir EJ Abel V Margulis","SH Culp NM Tannir EJ Abel V Margulis P Tamboli…"],"year":2010,"numCitations":166,"pdf":"https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.25046","citationUrl":"http://scholar.google.com/scholar?cites=14613047444424770876&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:PEXeOjr5y8oJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14613047444424770876&hl=en&as_sdt=0,5","publication":"Wiley Online Library"},{"title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1816714","authors":["BI Rini","BI Rini ER Plimack","BI Rini ER Plimack V Stus","BI Rini ER Plimack V Stus R Gafanov…"],"year":2019,"numCitations":545,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1816714","citationUrl":"http://scholar.google.com/scholar?cites=14370914940926626173&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:fQlJl_--b8cJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14370914940926626173&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the alliance A031203 …","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5455807/","authors":["TK Choueiri","TK Choueiri S Halabi","TK Choueiri S Halabi BL Sanford","TK Choueiri S Halabi BL Sanford O Hahn…"],"year":2017,"numCitations":386,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5455807/","citationUrl":"http://scholar.google.com/scholar?cites=5181895643400921433&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:WWEOAKLK6UcJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5181895643400921433&hl=en&as_sdt=0,5","publication":"ncbi.nlm.nih.gov"}]}